Drug intelligence / Profile preview

chloramphenicol + dexamethasone

Development stage
Phase 4
Lead developer
The Cooper Companies
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Ophthalmic, Otic, Topical
01

Overview

Chloramphenicol + dexamethasone is a fixed-dose combination drug consisting of two active ingredients: chloramphenicol, a broad-spectrum bacteriostatic antibiotic, and dexamethasone, a potent synthetic corticosteroid. Chloramphenicol inhibits bacterial protein synthesis by binding to the 50S subunit of bacterial ribosomes, thereby preventing the growth of both gram-positive and gram-negative bacteria. Dexamethasone exerts anti-inflammatory and immunosuppressive effects by inhibiting multiple inflammatory cytokines and mediators such as prostaglandins. This combination is primarily used topically (eye drops, ear drops, ointments) for the treatment of ocular or otic infections where inflammation coexists with or increases the risk for bacterial infection—such as conjunctivitis, keratitis, blepharitis, corneal ulcers (eye), otitis externa or media (ear), post-operative eye inflammation/infection prevention. The dual action addresses both infection control and symptomatic relief from inflammation[2][4][5][7].

Brand names
Dexachlor
Other names
chloramphenicol and dexamethasonedexamethasone + chloramphenicol
02

Targets

Bacterial 50S ribosomal subunitGR (Glucocorticoid receptor)

Beyond the preview

Go deeper on chloramphenicol + dexamethasone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on chloramphenicol + dexamethasone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call